Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

caplacizumab

(KAP-luh-SIH-zoo-mab)
A drug used with plasma exchange and immunosuppressive therapy to treat acquired thrombotic thrombocytopenic purpura (aTTP). aTTP is a rare blood disorder in which blood clots form in small blood vessels throughout the body. Caplacizumab binds to a protein called VWF, which may help keep blood clots from forming. It is a type of nanobody (a tiny antibody). Also called Cablivi.
Search NCI's Dictionary of Cancer Terms